Not such a bright idea: the UK risksharing scheme for beta interferon and glatiramer acetate in multiple sclerosis

E-ISSN： 1474-7766|3|4|194-195

ISSN： 1474-7758

Source： PRACTICAL NEUROLOGY, Vol.3, Iss.4, 2003-08, pp. : 194-195

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Beta-interferon and multiple sclerosis

By Hall G.L. Compston A. Scolding N.J.

Trends in Neurosciences, Vol. 20, Iss. 2, 1997-02 ,pp. : 63-67

Elsevier

Access to resources Recommend Favorite

Glatiramer acetate induced acute exacerbation of autoimmune hepatitis in a patient with multiple sclerosis

By Neumann Helmut Csepregi Antal Sailer Michael Malfertheiner Peter

Journal of Neurology, Vol. 254, Iss. 6, 2007-06 ,pp. : 816-817

Springer Publishing Company

Access to resources Recommend Favorite

Multiple sclerosis: glatiramer acetate inhibits monocyte reactivity in vitro and in vivo

By Weber Martin S.

Brain, Vol. 127, Iss. 6, 2004-06 ,pp. : 1370-1378

Oxford University Press

Access to resources Recommend Favorite

Psoriasis during interferon beta treatment for multiple sclerosis

By La Mantia Loredana Capsoni F.

Neurological Sciences, Vol. 31, Iss. 3, 2010-06 ,pp. : 337-339

Springer Publishing Company

Access to resources Recommend Favorite

Blocking effects of serum reactive antibodies induced by glatiramer acetate treatment in multiple sclerosis

By Salama Hassan H.

Brain, Vol. 126, Iss. 12, 2003-12 ,pp. : 2638-2647

Oxford University Press

Access to resources Recommend Favorite